Contract manufacturing said to be slowing; Lubrizol buys Particle Sciences;

> A new industry report says that growth of the biopharmaceutical contract manufacturing sector is likely to be slow because of high levels of capital investment by drugmakers. Report

> Bethlehem, PA-based CDMO Particle Sciences has been acquired by Lubrizol. Report

> A new report estimates that between 27% and 30% of India's $15 billion domestic drug business is controlled by foreign nationals. Release

> India is considering having thousands of drugmakers upgrade to PICS standards to help them access about 45 export markets. Report